Correlation Between Oasmia Pharmaceutical and BioAge Labs,
Can any of the company-specific risk be diversified away by investing in both Oasmia Pharmaceutical and BioAge Labs, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oasmia Pharmaceutical and BioAge Labs, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oasmia Pharmaceutical AB and BioAge Labs,, you can compare the effects of market volatilities on Oasmia Pharmaceutical and BioAge Labs, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oasmia Pharmaceutical with a short position of BioAge Labs,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oasmia Pharmaceutical and BioAge Labs,.
Diversification Opportunities for Oasmia Pharmaceutical and BioAge Labs,
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Oasmia and BioAge is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Oasmia Pharmaceutical AB and BioAge Labs, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAge Labs, and Oasmia Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oasmia Pharmaceutical AB are associated (or correlated) with BioAge Labs,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAge Labs, has no effect on the direction of Oasmia Pharmaceutical i.e., Oasmia Pharmaceutical and BioAge Labs, go up and down completely randomly.
Pair Corralation between Oasmia Pharmaceutical and BioAge Labs,
Assuming the 90 days horizon Oasmia Pharmaceutical is expected to generate 3.27 times less return on investment than BioAge Labs,. In addition to that, Oasmia Pharmaceutical is 4.76 times more volatile than BioAge Labs,. It trades about 0.0 of its total potential returns per unit of risk. BioAge Labs, is currently generating about 0.05 per unit of volatility. If you would invest 1,831 in BioAge Labs, on August 29, 2024 and sell it today you would earn a total of 98.00 from holding BioAge Labs, or generate 5.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 93.33% |
| Values | Daily Returns |
Oasmia Pharmaceutical AB vs. BioAge Labs,
Performance |
| Timeline |
| Oasmia Pharmaceutical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| BioAge Labs, |
Oasmia Pharmaceutical and BioAge Labs, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oasmia Pharmaceutical and BioAge Labs,
The main advantage of trading using opposite Oasmia Pharmaceutical and BioAge Labs, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oasmia Pharmaceutical position performs unexpectedly, BioAge Labs, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAge Labs, will offset losses from the drop in BioAge Labs,'s long position.| Oasmia Pharmaceutical vs. Inhibrx | Oasmia Pharmaceutical vs. Socket Mobile | Oasmia Pharmaceutical vs. Reservoir Media | Oasmia Pharmaceutical vs. Abcellera Biologics |
| BioAge Labs, vs. Titan Machinery | BioAge Labs, vs. Asure Software | BioAge Labs, vs. Kite Realty Group | BioAge Labs, vs. Cedar Realty Trust |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |